Alcon Inc. Ordinary Shares (NY:ALC)

63.76 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alcon Inc. Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Alcon to Present at 2023 Annual J.P. Morgan Healthcare Conference

December 28, 2022

From Alcon Inc. Investors

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022 ↗

December 22, 2022

Via Benzinga

5 Analysts Have This to Say About Alcon ↗

December 21, 2022

Via Benzinga

Alcon Prices US$1.3 Billion Senior Notes Offering

November 29, 2022

From Alcon Inc. Investors

Via Business Wire

Analyst Ratings for Alcon ↗

November 17, 2022

Via Benzinga

Where Alcon Stands With Analysts ↗

November 17, 2022

Via Benzinga

2 Surprising Movers in the Stock Market Today ↗

November 16, 2022

Investors didn't expect what these companies had to say.

Via The Motley Fool

Analyst Ratings for Alcon ↗

October 17, 2022

Alcon (NYSE:ALC) has observed the following analyst ratings within the last quarter:

Via Benzinga

Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business

November 22, 2022

From Alcon Inc. Investors

Via Business Wire

Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday ↗

November 17, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Via Benzinga

Where Alcon Stands With Analysts ↗

October 17, 2022

Alcon (NYSE:ALC) has observed the following analyst ratings within the last quarter:

Via Benzinga

Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session ↗

November 16, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Via Benzinga

Lowe's, Alcon And Some Other Big Stocks Moving Higher On Wednesday ↗

November 16, 2022

U.S. stocks traded lower, with the Nasdaq dropping more than 180 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Alcon Reports Third Quarter 2022 Results

November 15, 2022

From Alcon Inc. Investors

Via Business Wire

Earnings Scheduled For November 15, 2022 ↗

November 15, 2022

Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million.

Via Benzinga

Alcon to Celebrate 75 Years of Brilliance and Showcase Contact Lens Innovations at #Academy22

October 26, 2022

From Alcon Inc. Investors

Via Business Wire

Alcon: Take A Look At Vision Care ↗

October 23, 2022

Alcon AG is a global provider of ophthalmic surgery and vision care products. We have a favorable view of the company’s market position and product pipeline, and note that sales growth has outpaced...

Via Talk Markets

4 Analysts Have This to Say About Alcon ↗

October 17, 2022

Over the past 3 months, 4 analysts have published their opinion on Alcon (NYSE:ALC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...

Via Benzinga

Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022

September 29, 2022

From Alcon Inc. Investors

Via Business Wire

Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year ↗

September 19, 2022

The biotech run off a June bottom is great — until you realize you could've netted more.

Via Investor's Business Daily

Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday ↗

August 24, 2022

Gainers

Via Benzinga

Macy's, Palo Alto Networks And Other Big Gainers From Tuesday ↗

August 24, 2022

U.S. stocks closed mostly lower with the Dow Jones dropping more than 150 points on Tuesday. Here is the list of some big stocks moving higher in the previous session.

Via Benzinga

Alcon May Struggle To Meet 2023 Margin Targets With This Latest Acquisition, Says This Analyst ↗

August 23, 2022

Via Benzinga

Stocks Cut Lower As Dow Sheds Another Triple Digits ↗

August 23, 2022

Though most sectors are suffering today, especially real estate and healthcare, energy stocks are on the rise as oil prices make a big resurgence.

Via Talk Markets

Aerie Pharmaceuticals (NASDAQ: AERI) Enters into Agreement to be Acquired by Alcon (NYSE: ALC) for $770 Million

August 23, 2022

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) is engaged within the research, development and commercialization of ophthalmic therapies for the treatment of

Via Spotlight Growth

Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session ↗

August 23, 2022

Gainers

Via Benzinga

Why Is Aerie Pharmaceuticals (AERI) Stock Up 35% Today? ↗

August 23, 2022

Aerie Pharmaceuticals (AERI) stock is rising higher on Tuesday following news of a $770 million acquisition deal with Alcon (ALC).

Via InvestorPlace

Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million ↗

August 23, 2022

The biopharma buying spree continued Tuesday with glaucoma drugs maker Aerie.

Via Investor's Business Daily

Why Zoom Video Is Trading Lower By 11%; Here Are 28 Stocks Moving Premarket ↗

August 23, 2022

Gainers Quotient Limited (NASDAQ: QTNT) shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss.

Via Benzinga

Palo Alto Networks, Aerie Pharmaceuticals And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

August 23, 2022

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.